Oncotype DX-guided treatment could reduce cost for breast cancer care, study suggests

[News]

A new study suggests that Oncotype DX-guided treatment could reduce the cost for the first year of breast cancer care in the U.S. by about $50 million (about 2 percent of the overall costs in the first year).

More... (https://www.news-medical.net/news/20190424/Oncotype-DX-guided-treatment-could-reduce-cost-for-breast-cancer-care-study-suggests.aspx)